Skip to main content

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Investor Investigation Over Possible Violations Of Securities Laws

  • If you purchased shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Jan. 15, 2013 (Shareholders Foundation) -- An investigation on behalf of investors of Amicus Therapeutics, Inc. (NASDAQ:FOLD) shares over potential securities laws violations by Amicus Therapeutics, Inc. and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers ...

You must register (for free) or login to view the entire investigation.